Wnt signaling is a highly conserved signaling pathway that plays a critical role in controlling
embryonic and organ development, as well as cancer progression. Genome-wide …

Estrogen receptor-positive (ER+) breast cancer is the most common breast cancer subtype.
Treatment of ER+ breast cancer comprises interventions that suppress estrogen production …

Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …

Background Invasive lobular breast cancer (ILC) is the second most common type of breast
cancer after invasive breast cancer of no special type (NST), representing up to 15% of all …

Resistance to endocrine therapy remains a major clinical problem in breast cancer. Genetic
studies highlight the potential role of estrogen receptor-α (ESR1) mutations, which show …

Long non-coding RNAs play a significant role in cancer metastasis. Studies have
demonstrated that LncRNA NEAT1 promotes cancer progression. We aimed to explore …

Invasive lobular carcinoma (ILC) accounts for 10% to 15% of breast cancers in the United
States, 80% of which are estrogen receptor (ER)-positive, with an unusual metastatic pattern …

Abstract Invasive lobular carcinoma comprises 10–15% of all breast cancers and is
increasingly recognised as a distinct and understudied disease compared with the …

Background Invasive lobular breast carcinoma (ILC) is a histological subtype of breast
cancer that is characterized by loss of E-cadherin and high expression of estrogen receptor …

Invasive lobular carcinoma (ILC) is the most frequent special histological subtype of breast
cancer, typically characterized by loss of E‐cadherin. It has clinical features distinct from …